LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Начало・Списък с акции・Boston Scientific Corp.

Boston Scientific Corp.

Затворен

СекторЗдравеопазване

57.61 1.02

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

57.41

Максимум

57.67

Ключови измерители
By Trading Economics
Приходи	669M 1.3B
Продажби	-83M 5.2B
P/E Средно за сектора	23.398 49.701
EPS	0.8
Марж на печалбата	25.774
Служители	59,000
EBITDA	116M 1.1B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+51.66% upside

Дивиденти
By Dow Jones
Следващи печалби	29.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-7.5B 83B
Предишно отваряне	56.59
Предишно затваряне	57.61

Настроения в новините

By Acuity

26%

74%

59 / 345 Класиране в Healthcare

Boston Scientific Corp. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.05.2026 г., 11:04 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific Buys 34% Stake in MiRus for $1.5 Billion

22.04.2026 г., 11:22 ч. UTC

Печалби

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

4.02.2026 г., 16:14 ч. UTC

Печалби

Значими двигатели на пазара

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

4.02.2026 г., 12:13 ч. UTC

Печалби

Boston Scientific Sees More Growth after Earnings, Sales Rise

6.05.2026 г., 20:15 ч. UTC

Печалби

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6.05.2026 г., 20:07 ч. UTC

Печалби

Penumbra 1Q Rev $374.8M >PEN

6.05.2026 г., 20:07 ч. UTC

Печалби

Penumbra 1Q EPS 82c >PEN

22.04.2026 г., 11:07 ч. UTC

Печалби

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

22.04.2026 г., 10:32 ч. UTC

Печалби

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

22.04.2026 г., 10:31 ч. UTC

Печалби

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific 1Q Adj EPS 80c >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific 1Q EPS 90c >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific 1Q Sales $5.2B >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

22.04.2026 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

30.03.2026 г., 15:34 ч. UTC

Пазарно говорене

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

4.02.2026 г., 21:41 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4.02.2026 г., 19:38 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4.02.2026 г., 17:32 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

4.02.2026 г., 15:30 ч. UTC

Печалби

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

4.02.2026 г., 15:29 ч. UTC

Печалби

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

4.02.2026 г., 14:06 ч. UTC

Печалби

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

4.02.2026 г., 13:58 ч. UTC

Печалби

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4.02.2026 г., 13:12 ч. UTC

Печалби

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4.02.2026 г., 11:32 ч. UTC

Печалби

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

4.02.2026 г., 11:31 ч. UTC

Печалби

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

4.02.2026 г., 11:30 ч. UTC

Печалби

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

4.02.2026 г., 11:30 ч. UTC

Печалби

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

4.02.2026 г., 11:30 ч. UTC

Печалби

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

Сравнение с други в отрасъла

Ценова промяна

Boston Scientific Corp. Прогноза

Ценова цел

By TipRanks

51.66% нагоре

12-месечна прогноза

Среден 87.63 USD 51.66%

Висок 118 USD

Нисък 68 USD

Според 27 анализатори от Wall Street, предложили 12-месечна ценова цел за Boston Scientific Corp. през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

27 ratings

Купи

Задържане

Продай

Според 27 анализатори, дали борсови рейтинги на Boston Scientific Corp. през последните 3 месеца.

Настроение

By Acuity

59 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.